| Typicality: | 0.250 |
| Saliency: | 0.000 |
| in combination with sofosbuvir | 3 | other |
| for 12 weeks | 3 | temporal |
| cirrhosis → receive → daklinza | 3 |
| negative | neutral | positive |
| 0.067 | 0.756 | 0.176 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 477.498 |